Inspire Medical Systems (INSP) Net Cash Flow Growth (1y) (2018 - 2026)
Inspire Medical Systems (INSP) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | 76.43% |
| 10 | Inspire Medical Systems | 1.46 Bn | 1.18 Bn | 176.91 Mn | 93.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.87% |
| Dec 31, 2025 | -376.64% |
| Sep 30, 2025 | 114.22% |
| Jun 30, 2025 | 319.22% |
| Mar 31, 2025 | -869.17% |
| Dec 31, 2024 | 101.94% |
| Sep 30, 2024 | 70.24% |
| Jun 30, 2024 | -49.32% |
| Mar 31, 2024 | -1,955.24% |
| Dec 31, 2023 | -712.38% |
| Sep 30, 2023 | -159.26% |
| Jun 30, 2023 | 248.75% |
| Mar 31, 2023 | 104.78% |
| Dec 31, 2022 | 451.98% |
| Sep 30, 2022 | 587.48% |
| Jun 30, 2022 | -189.31% |
| Mar 31, 2022 | -36.67% |
| Dec 31, 2021 | -63.78% |
| Sep 30, 2021 | 203.47% |
| Jun 30, 2021 | -104.29% |